Metraipolis › archive › dc_d16797bee5a4

Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic… — Europe PMC PMID:41541220

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41541220
DOI
10.1093/noajnl/vdaf241
License (as archived)
solo-consultazione
Archived
2026-11-08T14:50:54.299Z
SHA-256 of the archived text
9e257247cfbb78b77de89184ea4a9d63be32996585407eba59d46488ba04d3b7
Stable URL of this page
https://metraipolis.com/documento/dc_d16797bee5a4

How to cite

Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic… — Europe PMC PMID:41541220 — Europe PMC (en), https://europepmc.org/article/MED/41541220 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d16797bee5a4 (Metraipolis archive dc_d16797bee5a4, sha256 9e257247cfbb78b77de89184ea4a9d63be32996585407eba59d46488ba04d3b7)
BibTeX
@misc{dcd16797bee5a4,
  title = {Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic… — Europe PMC PMID:41541220},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41541220},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d16797bee5a4; sha256 9e257247cfbb78b77de89184ea4a9d63be32996585407eba59d46488ba04d3b7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41541220. Agents can read the archived copy with the MCP tool read_document.